Background Critical examination of the quality and validity of available allergic rhinitis (AR)
literature is necessary to improve understanding and to appropriately translate this …

Atopic dermatitis (atopic eczema) is a chronic relapsing and remitting inflammatory skin
disease affecting one in 10 people in their lifetime. Atopic dermatitis is caused by a complex …

Recently published data from high-impact randomized controlled trials indicate the strong
potential of strategies to prevent the development of food allergy in high-risk individuals, but …

Introduction: Allergy results from an aberrant Type 2 inflammatory response, triggered by a
wide range of environmental antigens (allergens) that lead to various immune responses …

Background Additional topical treatments for atopic dermatitis (AD) are needed that provide
relief while minimizing risks. Objective We sought to assess the efficacy and safety of …

Background Interleukin (IL)-13 plays a key role in type 2 inflammation and is an emerging
pathogenic mediator in atopic dermatitis (AD). Objective We investigated the efficacy and …

This review focuses on advances and updates in the epidemiology, pathogenesis,
diagnosis, and treatment of food allergy over the past 3 years since our last comprehensive …

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of
children and 2% to 3% of adults. This guideline addresses important clinical questions that …

Atopic dermatitis is a common and chronic, pruritic inflammatory skin condition that can
affect all age groups. This evidence-based guideline addresses important clinical questions …

Staphylococcus aureus skin colonization is universal in atopic dermatitis and common in
cancer patients treated with epidermal growth factor receptor inhibitors. However, the causal …